Chemical Works of Gedeon Richter Plc (RGEDF)
41.20
+0.76
(+1.87%)
USD |
OTCM |
Oct 26, 16:00
Chemical Works of Gedeon Richter Market Cap : 7.543B for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 7.543B |
| October 23, 2026 | 7.404B |
| October 22, 2026 | 7.218B |
| October 21, 2026 | 7.218B |
| October 20, 2026 | 7.291B |
| October 19, 2026 | 7.256B |
| October 16, 2026 | 7.180B |
| October 15, 2026 | 7.073B |
| October 14, 2026 | 6.955B |
| October 13, 2026 | 7.058B |
| October 12, 2026 | 7.025B |
| October 09, 2026 | 6.797B |
| October 08, 2026 | 6.545B |
| October 07, 2026 | 6.591B |
| October 06, 2026 | 7.058B |
| October 05, 2026 | 6.944B |
| October 02, 2026 | 7.023B |
| October 01, 2026 | 7.031B |
| September 30, 2026 | 7.165B |
| September 29, 2026 | 7.088B |
| September 28, 2026 | 7.116B |
| September 25, 2026 | 7.239B |
| September 24, 2026 | 7.094B |
| September 23, 2026 | 7.126B |
| September 22, 2026 | 7.505B |
| Date | Value |
|---|---|
| September 21, 2026 | 7.666B |
| September 18, 2026 | 7.511B |
| September 17, 2026 | 7.595B |
| September 16, 2026 | 7.346B |
| September 15, 2026 | 7.195B |
| September 14, 2026 | 7.348B |
| September 11, 2026 | 7.212B |
| September 10, 2026 | 7.499B |
| September 09, 2026 | 7.441B |
| September 08, 2026 | 7.443B |
| September 04, 2026 | 7.576B |
| September 03, 2026 | 7.362B |
| September 02, 2026 | 7.460B |
| September 01, 2026 | 7.722B |
| August 31, 2026 | 7.727B |
| August 28, 2026 | 7.918B |
| August 27, 2026 | 7.918B |
| August 26, 2026 | 7.955B |
| August 25, 2026 | 8.012B |
| August 24, 2026 | 7.929B |
| August 21, 2026 | 7.654B |
| August 20, 2026 | 7.654B |
| August 19, 2026 | 7.781B |
| August 18, 2026 | 7.638B |
| August 17, 2026 | 7.695B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 529.36B |
| ANI Pharmaceuticals, Inc. | 1.639B |
| Corcept Therapeutics, Inc. | 9.425B |
| Veru, Inc. | 38.36M |
| Avadel Pharmaceuticals Plc | 2.104B |
Market Cap Related Metrics
| PE Ratio | 11.45 |
| PS Ratio | 2.660 |
| PEG Ratio | 1.055 |
| Price to Book Value | 1.727 |
| Price to Free Cash Flow | 9.329 |
| Price | 41.20 |
| Earnings Yield | 8.74% |
| PEGY Ratio | 0.7129 |
| Operating PE Ratio | 7.511 |
| Normalized PE Ratio | 11.44 |